DAIsy
Developing AI ecosystems improving diagnosis and care of mental diseases
Project description
Major depressive disorder (MDD) is a common psychiatric disorder, ranking as the second leading contributor of years
lived with disability. Finding the right approach for individual patients remains challenging. DAIsy will develop and bring
to the market AI-supported solutions for improved diagnosis, treatment selection, diet monitoring, activity tracking,
support in behaviour adjustments, and treatment response assessment. Novel AI techniques will be jointly developed
to advance the AI applicability for these fragile patients by advancing techniques for large data points/patient ratios,
improving explainability and uncertainty quantification.
https://daisy-project.org
Germany
The Netherlands
5M Software
The Netherlands
Academic Medical Centre Amsterdam (AMC)
The Netherlands
Eindhoven University of Technology
The Netherlands
GGZ Oost-Brabant
The Netherlands
MEDrecord BV
The Netherlands
Philips Electronics Nederland BV
The Netherlands
SemLab
The Netherlands
Türkiye
ARD GROUP
Türkiye
Bewell Teknololji San.Tic.A.Ş.
Türkiye
NP ISTANBUL BRAIN HOSPITAL
Türkiye
Vestel Sağlık Teknolojileri AŞ
Türkiye
Project publications
- DAIsy Project profile leaflet Project Leaflet 14 August 2024 Download
- ITEA PO Days 2024 - Project poster DAIsy Project poster 11 September 2024
- Innovatieproject voor geestelijke gezondheid Press article 17 November 2023
- Unieke Europese subsidie 'Big data en digitalisering' voor Hoogspecialistisch centrum voor Eetstoornissen Press article 17 November 2023
Work package documents
- DAISy_WP7_DELIVERABLE - 7.4.pdf Work package deliverable document 23 February 2024
- DAISy_WP7_DELIVERABLE - 7.5 (18M).pdf Work package deliverable document 27 November 2024